R&D Systems™ Recombinant Human Common gamma Chain Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human Common gamma Chain Protein is derived from Sf 21 (baculovirus). The Recombinant Human Common gamma Chain Protein has been validated for the following applications: Bioactivity.

Specifications

• Formulation: Lyophilized from a 0.2μm filtered solution in PBS with BSA as a carrier protein.
• Gene ID (Entrez): 3561
• Molecular Weight (g/mol): 28.2 kDa
• Name: Common gamma Chain/IL-2 R gamma
• Quantity: 50 μg
• Source: Spodoptera frugiperda,Sf 21 (baculovirus)-derived human Common gamma Chain/IL-2 R gamma protein Leu23-Asn254,with a C-terminal 6-His tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Activity: Measured by its ability to inhibit the IL-2-dependent proliferation of MO7e human megakaryocytic leukemic cells. The ED50 for this effect is typically 0.6-3.6 μg/mL in the presence of 30 μg/mL of soluble IL-2 R beta and 10 ng/mL of recombinant human IL-2.
• Purity or Quality Grade: 97%, by SDS-PAGE under reducing conditions and visualized by silver stain.